Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling

Releasing Hormone ◽

Prostate Cancers ◽

Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone

British Journal of Cancer ◽

10.1038/bjc.1997.271 ◽

1997 ◽

Vol 75 (11) ◽

pp. 1585-1592 ◽

Cited By ~ 51

Author(s):

A Jungwirth ◽

AV Schally ◽

J Pinski ◽

G Halmos ◽

K Groot ◽

...

Keyword(s):

Growth Hormone ◽

Releasing Hormone ◽

Prostate Cancers ◽

Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers

The Prostate ◽

10.1002/pros.20262 ◽

2005 ◽

Vol 64 (3) ◽

pp. 303-315 ◽

Cited By ~ 34

Author(s):

Anton Stangelberger ◽

Andrew V. Schally ◽

Jozsef L. Varga ◽

Brian D. Hammann ◽

Kate Groot ◽

...

Keyword(s):

Growth Hormone ◽

Releasing Hormone ◽

Her Family ◽

Gastrin Releasing Peptide ◽

Prostate Cancers ◽

Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins

The Prostate ◽

10.1002/pros.21458 ◽

2011 ◽

Vol 72 (5) ◽

pp. 555-565 ◽

Cited By ~ 22

Author(s):

Anton Stangelberger ◽

Andrew V. Schally ◽

Ferenc G. Rick ◽

Jozsef L. Varga ◽

Benjamin Baker ◽

...

Keyword(s):

Growth Hormone ◽

Mutant P53 ◽

Wild Type ◽

Inhibitory Effects ◽

Releasing Hormone ◽

Wild Type P53 ◽

Diverse intracellular signalling systems used by growth hormone‐releasing hormone in regulating voltage‐gated Ca 2+ or K + channels in pituitary somatotropes

Immunology and Cell Biology ◽

10.1046/j.1440-1711.2000.00917.x ◽

2000 ◽

Vol 78 (4) ◽

pp. 356-368 ◽

Cited By ~ 30

Author(s):

Chen Chen ◽

Ruwei Xu ◽

Iain J Clarke ◽

Ming Ruan ◽

Kylie Loneragan ◽

...

Keyword(s):

Growth Hormone ◽

Intracellular Signalling ◽

K Channels ◽

Releasing Hormone ◽

Voltage Gated ◽

Signalling Systems

Antagonists of growth hormone-releasing hormone (GH-RH) enhance tumour growth inhibition induced by androgen deprivation in human MDA-Pca-2b prostate cancers

European Journal of Cancer ◽

10.1016/j.ejca.2003.10.010 ◽

2004 ◽

Vol 40 (3) ◽

pp. 436-444 ◽

Cited By ~ 9

Author(s):

M. Letsch ◽

A.V. Schally ◽

A. Stangelberger ◽

K. Groot ◽

J.L. Varga

Keyword(s):

Growth Hormone ◽

Growth Inhibition ◽

Tumour Growth ◽

Androgen Deprivation ◽

Releasing Hormone ◽

Tumour Growth Inhibition ◽

Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers

Peptides ◽

10.1016/s0196-9781(02)00043-8 ◽

2002 ◽

Vol 23 (6) ◽

pp. 1127-1133 ◽

Cited By ~ 25

Author(s):

Artur Plonowski ◽

Andrew V Schally ◽

Rebeca Busto ◽

Magdalena Krupa ◽

Jozsef L Varga ◽

...

Keyword(s):

Growth Hormone ◽

Splice Variants ◽

Releasing Hormone ◽

Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.0337496100 ◽

2003 ◽

Vol 100 (3) ◽

pp. 1250-1255 ◽

Cited By ~ 54

Author(s):

M. Letsch ◽

A. V. Schally ◽

R. Busto ◽

A. M. Bajo ◽

J. L. Varga

Keyword(s):

Growth Hormone ◽

Releasing Hormone ◽

Ghrh Antagonists ◽

Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity

International Journal of Cancer ◽

10.1002/ijc.10221 ◽

2002 ◽

Vol 98 (4) ◽

pp. 624-629 ◽

Cited By ~ 20

Author(s):

Artur Plonowski ◽

Jozsef L. Varga ◽

Andrew V. Schally ◽

Magdalena Krupa ◽

Kate Groot ◽

...

Keyword(s):

Growth Hormone ◽

Vasoactive Intestinal Peptide ◽

Antagonistic Activity ◽

Human Prostate ◽

Releasing Hormone ◽

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.1120588109 ◽

2012 ◽

Vol 109 (5) ◽

pp. 1655-1660 ◽

Cited By ~ 48

Author(s):

F. G. Rick ◽

A. V. Schally ◽

L. Szalontay ◽

N. L. Block ◽

K. Szepeshazi ◽

...

Keyword(s):

Prostate Cancer ◽

Growth Hormone ◽

Releasing Hormone ◽

Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.95.15.8864 ◽

1998 ◽

Vol 95 (15) ◽

pp. 8864-8868 ◽

Cited By ~ 60

Author(s):

N. Lamharzi ◽

A. V. Schally ◽

M. Koppan ◽

K. Groot

Keyword(s):

Growth Hormone ◽

Growth Factor ◽

Mrna Expression ◽

Nude Mice ◽

Prostate Carcinoma ◽

Insulin Like Growth Factor ◽

Releasing Hormone ◽

Factor Ii ◽